Tumor suppressor gene alterations in patients with malignant mesothelioma due to environmental asbestos exposure in Turkey

Journal of Carcinogenesis

Volumn 5, Issue , 2006, Pages

  Tug, Esra ^a   Tug, Tuncer ^a   Elyas, Halit ^b   Coskunsel, Mehmet ^c   Emri, Salih ^d  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; GENOMIC DNA; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; ASBESTOSIS; BLOOD SAMPLING; CHROMOSOME 6Q; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA ISOLATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE LOCUS; GENE LOSS; GENETIC VARIABILITY; GENOTOXICITY; HETEROZYGOSITY LOSS; HUMAN; LUNG TOXICITY; MALE; MALIGNANT MESOTHELIOMA; MOLECULAR GENETICS; PATHOPHYSIOLOGY; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; TIME SERIES ANALYSIS; TURKEY (REPUBLIC);

EID: 33748365258     PISSN: 14773163     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-5-23     Document Type: Article

References (23)

1. Dogan M, Emri S: Environmental health problems related to mineral dusts in Ankara and Eskisehir, Turkey. Yerbilimleri 2000, 22:149-61.
2. Baris YI: Asbestos and Erionite Related Chest Diseases Ankara-Turkey; 1987:36-102.
3. Emri S, Demir A, Dogan M, et al: Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicology Letters 2002, 127(1-3):251-7.
4. Baris YI: Lung diseases related to asbestos and fibrous zeolite exposure in Turkey. In The symposium on nutrition, environment, and cancer Ankara, Turkey. March 31-April 3, 2002.
5. Billings CG, Howard P: Asbestos exposure, lung cancer and asbestosis. Monaldi Arch Chest Dis 2000, 55:151-6.
6. Lee WC, Testa JR: Somatic genetic alteration in human malignant mesothelioma. Int J Oncol 1999, 14:181-8.
7. Attanoos RL, Gibbs AR: Pathology of malignant mesothelioma. Histopathology 1997, 30:403-18.
8. Selcuk ZT, Coplu L, Emri S, Kalyoncu AF, Sahin AA, Baris YI: Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest 1992, 102:790-6.
9. Balsara BR, Bell DW, Sonoda G, Rienzo AD, Manoir S, Jhanwar SC, Testa JR: Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res 1999, 59:450-4.
10. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR: Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 1993, 53:4349-55.
11. Murthy SS, Testa JR: Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol 1999, 180:150-7.
12. Bell DW, Jhanwar SC, Testa JR: Multiple region of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res 1997, 57:4057-62.
13. Senyigit A, Babyigit C, Gokirmak M, Topcu F, Asan E, Coskunsal M, Isik R, Ertem M: Incidence of malignant plueral mesothelioma due to environmental asbestos fiber exposure in the Southeast of Turkey. Respiration 2000, 67:610-4.
14. Dumortier P, Coplu L, de Maertelaer V, Emri S, Baris I, De Vuyst P: Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med 1998, 158:1815-24.
15. Masood R, Kundra A, Zhu S, Xia G, Scalia P, Smith DL, Gill PS: Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int J Cancer 2003, 104:603-10.
16. Emri S, Akbulut H, Zorlu F, Dincol D, Akay H, Gungen Y, Icli F: Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer 2001, 33:109-14.
17. Ribotta M, Roseo F, Salvio M, Castagneto B, Carbone M, Procopio A, Giordano A, Muti L: Recurrent chromosome 6 abnormalities in malignant mesothelioma. Monaldi Arch Chest Dis 1998, 53:228-35.
18. Sheng ZM, Marchetti A, Buttitta F, Champeme MH, Campani D, Bistochi M, Lidereau R, Callahan R: Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer 1996, 73:144-7.
19. Orphanos V, Mc Grown G, Hey Y, Thorncroft M, Santibanez-Koref M, Russell SEH, Hickey I, Atkinson RJ, Boyle JM: Allelic imbalance of chromosome 6q in ovarian tumors. Br J Cancer 1995, 71:666-9.
20. Vaslet CA, Messier NJ, Kane AB: Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+/mice. Toxicol Sci 2002, 68:331-38.
21. Bocchetta M, Miele L, Pass HI, Carbone M: Notch-1 induction, a novel activity of SV 40 required for growth of SV40-transformed human mesothelial cells. Oncogene 2003, 22:81-9.
22. Vivo C, Lecomte C, Levy F, Leroy K, Kirova Y, Renier A, Kheuang L, Piedbois P, Chopin D, Jaurand MC: Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation. Br J Cancer 2003, 88:38895.
23. Emri S, Kocagoz T, Olut A, Güngen Y, Mutti L, Baris YI: Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Res 2000, 20:891-4.